The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages

Infection and Immunity

Volumn 80, Issue 5, 2012, Pages 1650-1661

  Cumley, Nicola J ^a   Smith, Leanne M ^a   Anthony, Mark ^b   May, Robin C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COVR PROTEIN; COVS PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATION; CONTROLLED STUDY; MACROPHAGE; MENINGITIS; MOUSE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; NONHUMAN; PH; PHAGOSOME; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; PERFORIN; PHAGOSOMES; PIGMENTS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; STREPTOCOCCUS AGALACTIAE; VIRULENCE FACTORS;

EID: 84861162577     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05443-11     Document Type: Article

References (51)

1. Basset C, Holton J, O'Mahony R, Roitt I. 2003. Innate immunity and pathogen-host interaction. Vaccine 21:S12-S23.
2. Bates GW, Wernicke J. 1971. The kinetics and mechanism of iron(III) exchange between chelates and transferrin. J. Biol. Chem. 246:3679-3685.
3. Berner R. 2002. Group B streptococci during pregnancy and infancy. Curr. Opin. Infect. Dis. 15:307-313.
4. Brochet M, et al. 2006. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect. 8:1227-1243.
5. Brown SM, Campbell LT, Lodge JK. 2007. Cryptococcus neoformans, a fungus under stress. Curr. Opin. Microbiol. 10:320-325.
6. Brown SM, Upadhya R, Shoemaker JD, Lodge JK. 2010. Isocitrate dehydrogenase is important for nitrosative stress resistance in Cryptococ-cus neoformans, but oxidative stress resistance is not dependent on glucose-6-phosphate dehydrogenase. Eukaryot. Cell 9:971-980.
7. Byrd TF, Horwitz MA. 1991. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J. Clin. Invest. 88:351-357.
8. Carlin AF, et al. 2009. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 206:1691-1699.
9. Carlin AF, et al. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333-3336.
10. Cheng Q, et al. 2001. Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect. Immun. 69:2302-2308.
11. Clancy A, et al. 2006. Evidence for siderophore-dependent iron acquisition in group B streptococcus. Mol. Microbiol. 59:707-721.
12. Cornacchione S, et al. 1998. Group B streptococci persist inside macrophages. Immunology 93:86-95.
13. Drose S, Altendorf K. 1997. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
14. Edwards MS, Baker CJ. 2005. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41:839-847.
15. Flannagan RS, Cosio G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Micro. 7:355-366.
16. Forquin M-P, et al. 2007. The putative glycosyltransferase-encoding gene cylJ and the group B streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Infect. Immun. 75:2063-2066.
17. Fortier A, et al. 1995. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect. Immun. 63:1478-1483.
18. Glaser P, et al. 2002. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45:1499-1513.
19. Herbert M, et al. 2005. Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other group B streptococcal strains. BMC Microbiol. 5:31.
20. HPA. 2010. Pyogenic and non-pyogenic streptococcal bacteraemia, England, Wales and Northern Ireland: 2009. Health protection report, infection reports 4. HPA, London, United Kingdom.
21. Hu S, Sheng W, Schachtele S, Lokensgard J. 2011. Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J. Neuroinflammation 8:123.
22. Jiang S-M, Cieslewicz MJ, Kasper DL, Wessels MR. 2005. Regulation of virulence by a two-component system in group B Streptococcus. J. Bacteriol. 187:1105-1113.
23. Jiang S-M, et al. 2008. Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. J. Bacteriol. 190:1956-1965.
24. Johri AK, et al. 2006. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Micro. 4:932-942.
25. Kaplan EL, Chhatwal GS, Rohde M. 2006. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin. Infect. Dis. 43:1398-1406.
26. Kinchen JM, Ravichandran KS. 2008. Phagosome maturation: going through the acid test. Nat. Rev. Mol. Cell Biol. 9:781-795.
27. Lamothe J, Valvano MA. 2008. Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages. Microbiology 154:3825-3834.
28. Lamy M-C, et al. 2004. CovS/CovR of group B Streptococcus: a twocomponent global regulatory system involved in virulence. Mol. Microbiol. 54:1250-1268.
29. Lembo A, et al. 2010. Regulation of CovR expression in group B Streptococcus impacts blood-brain barrier penetration. Mol. Microbiol. 77: 431-443.
30. Levitz SM, Harrison TS, Tabuni A, Liu X. 1997. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J. Clin. Invest. 100:1640-1646.
31. Liu GY, et al. 2004. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc. Natl. Acad. Sci. U. S. A. 101:14491-14496.
32. Maisey HC, Doran KS, Nizet V. 2008. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Exp. Rev. Mol. Med. 10:e27.
33. Maisey HC, et al. 2008. A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 22:1715-1724.
34. Manning SD, et al. 2009. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J. Clin. Microbiol. 47:1143-1148.
35. Marques MB, Kasper DL, Pangburn MK, Wessels MR. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
36. Martin TR, Rubens CE, Wilson CB. 1988. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J. Infect. Dis. 157: 91-100.
37. Medina E, Goldmann O, Toppel AW, Chhatwal GS. 2003. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J. Infect. Dis. 187:597-603.
38. Pethe K, et al. 2004. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl. Acad. Sci. U. S. A. 101:13642-13647.
39. Poyart C, et al. 2001. Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect. Immun. 69:5098-5106.
40. Quentin R, et al. 1995. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J. Clin. Microbiol. 33:2576-2581.
41. Ralph P, Nakoinz I. 1975. Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257:393-394.
42. Rubens CE, Heggen LM, Haft RF, Wessels MR. 1993. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol. Microbiol. 8:843-855.
43. Santi I, et al. 2007. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol. Microbiol. 63:754-767.
44. Santi I, et al. 2009. CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development. J. Bacteriol. 191:5387-5397.
45. Stefanska J, Pawliczak R. 2008. Apocynin: molecular aptitudes. Mediators Inflamm. doi:10.1155/2008/106507.
46. Tazi A, et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med. 207: 2313-2322.
47. Tettelin H, et al. 2002. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. U. S. A. 99:12391-12396.
48. Thwaites GE, Gant V. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat. Rev. Micro 9:215-222.
49. Valenti-Weigand P, Benkel P, Rohde M, Chhatwal G. 1996. Entry and intracellular survival of group B streptococci in J774 macrophages. Infect. Immun. 64:2467-2473.
50. Voelz K, Johnston SA, Rutherford JC, May RC. 2010. Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One 5:e15968.
51. Weisner AM, et al. 2004. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin. Infect. Dis. 38:1203-1208.